跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACARIZAX - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ACARIZAX
Authorized
STANDARD
ACARIZAX
ALK-ABELLO A/S
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
dc5eee488380a7b2
Company
ALK-ABELLO A/S
Type
Standard
Approval Details
Approval Id
dc5eee488380a7b2
Drug Approval Canada Name
ACARIZAX
Product Name
ACARIZAX
Status
Marketed
Status Date
2017-11-06
Original Market Date
2017-11-06
Din
02463644
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Sublingual
Schedule
Schedule D , Prescription
Ahfs
92:05.00*
Atc Original
V01AA03 HOUSE DUST MITES
Atc Name
v 01 aa 03
Aig Number
0223339003
Company Name
ALK-ABELLO A/S
Company Address
Boege Alle 6-8, Hoersholm, --, Denmark, 2970
Active Ingredients
DERMATOPHAGOIDES FARINAE
6 UNIT
DERMATOPHAGOIDES PTERONYSSINUS
6 UNIT
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
dc5eee488380a7b2
Type
Standard
Back to Health Canada Approvals